VOCEPLY Trademark
Trademark Overview
On Monday, September 8, 2025, a trademark application was filed for VOCEPLY with the United States Patent and Trademark Office. The USPTO has given the VOCEPLY trademark a serial number of 99379533. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 26, 2026. This trademark is owned by Glaxo Group Limited. The VOCEPLY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases
General Information
| Serial Number | 99379533 |
| Word Mark | VOCEPLY |
| Filing Date | Monday, September 8, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 26, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 8, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | Stevenage SG12NY
GB |
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Monday, September 8, 2025 | NEW APPLICATION ENTERED |
| Monday, September 8, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 8, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 21, 2026 | ASSIGNED TO EXAMINER |
| Tuesday, January 27, 2026 | SUSPENSION LETTER WRITTEN |
| Tuesday, January 27, 2026 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 27, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, April 20, 2026 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, April 20, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 20, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 29, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 20, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 26, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 26, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
